GlassScriptPhysician profile
Ga Y Lee
NPI 1497918254
$3,092.35
in general payments reported to CMS, 2019-2025
30 companies · $438 in 2025
The $438 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $369 · 2021: $510 · 2022: $501 · 2023: $495 · 2024: $252 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.19 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,194.75 | 2019-2023 | |
| Astellas Pharma US INC | $253.57 | 2024-2025 | Veozah |
| Pfizer INC. | $212.40 | 2020-2024 | |
| Exeltis, USA INC. | $210.51 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $106.84 | 2019-2022 | |
| Millicent US INC | $100.67 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Avion Pharmaceuticals | $83.45 | 2019-2022 | |
| Agile Therapeutics, INC. | $72.57 | 2021-2023 | Twirla |
| Allergan, INC. | $72.37 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $71.51 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.34 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $60.84 | 2019-2020 | |
| Hologic Sales and Service, LLC | $59.32 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Myriad Genetic Laboratories, INC. | $52.88 | 2023 | Myrisk |
| Kowa Pharmaceuticals America, INC. | $50.78 | 2023 | Seglentis |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $47.88 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $47.80 | 2022-2023 | Ova1 |
| Lupin INC. | $44.04 | 2019 | |
| Mimedx Group, INC. | $43.80 | 2025 | |
| Daiichi Sankyo INC. | $40.30 | 2020-2021 | |
| Organon LLC | $31.23 | 2024 | |
| Axonics, INC. | $25.04 | 2021 | |
| Duchesnay USA Incorporated | $24.71 | 2019 | |
| Evofem Biosciences, INC. | $22.31 | 2022 | |
| Amgen INC. | $20.60 | 2019 | |
| Meditrina | $18.44 | 2024 | |
| Scynexis, INC. | $16.67 | 2022 | |
| Merck Sharp & Dohme LLC | $14.29 | 2019 | |
| Exact Sciences Corporation | $13.12 | 2023 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ga Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.